|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 10.29 USD | -6.45% |
|
+5.11% | +67.32% |
| 05-15 | ImmuCell Corporation, Q1 2026 Earnings Call, May 15, 2026 | |
| 05-14 | ImmuCell Corporation Reports Earnings Results for the First Quarter Ended March 31, 2026 | CI |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Sector Other Pharmaceuticals
| Capi. | Sales Growth | Profitability | Finances | EV / Sales | P/E | |
|---|---|---|---|---|---|---|
 | 93.09M | - | - | - | - | - |
| 1,082B | |||||
| 633B | |||||
| 461B | |||||
| 339B | |||||
| 301B |
- Stock Market
- Stocks
- ICCC Stock
- Charts ImmuCell Corporation
- Sector Chart
Select your edition
All financial news and data tailored to specific country editions
